Genotoxicity of all-trans retinoic acid (ATRA) and its steroidal analogue EA-4 in human lymphocytes and mouse cells in vitro

Cancer Letters

Volumn 306, Issue 1, 2011, Pages 15-26

  Alakhras, Raghda S ^a   Stephanou, Georgia ^a   Demopoulos, Nikos A ^a   Nikolaropoulos, Sotiris S ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

ATRA Retinoids; Chromosome breakage; Chromosome delay; Micronucleation; Mitotic spindle defect; Multinucleation

Indexed keywords

BETA TUBULIN; EA 4; GAMMA TUBULIN; RETINOIC ACID; RETINOIC ACID DERIVATIVE; STEROID; UNCLASSIFIED DRUG;

ANAPHASE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL NUCLEUS; CHROMOSOME BREAKAGE; CHROMOSOME DUPLICATION; CHROMOSOME STRUCTURE; CONTROLLED STUDY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERPHASE; LYMPHOCYTE; MICROTUBULE; MITOSIS SPINDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TELOPHASE;

ANIMALS; CELL CYCLE; CELL NUCLEUS; CENTROSOME; CHROMOSOMES; DNA DAMAGE; HUMANS; LYMPHOCYTES; MICE; MICROSCOPY, FLUORESCENCE; MICROTUBULES; MITOSIS; MITOTIC SPINDLE APPARATUS; MUTAGENS; STEROIDS; TRETINOIN;

EID: 79955478361     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.02.010     Document Type: Article

References (64)

1. Njar V.C., Gediya L., Purushottamachar P., Chopra P., Vasaitis T.S., Khandelwal A., Mehta J., Huynh C., Belosay A., Patel J. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg. Med. Chem. 2006, 13:4323-4340.
2. Degos L., Dombret H., Chomienne C., Daniel M.T., Micléa J.M., Chastang C., Castaigne S., Fenaux P. Alltrans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 1995, 85:2643-2653.
3. Moon R.C., Thompson H.J., Becci P.J., Grubbs C.J., Gander R.J., Newton D.L., Smith J.M., Phillips S.L., Henderson W.R., Mullen L.T., Brown C.C., Sporn M.B. N-(4-Hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979, 39:1339-1346.
4. Shealy Y.F., Frye J.L., O'Dell C.A., Thorpe M.C., Kirk M.C., Coburn W.C., Sporn M.B. Synthesis and properties of some 13-cis- and all-trans-retinamides. J. Pharm. Sci. 1984, 73:745-751.
5. Costa A., Formelli F., Chiesa F., Decensi A., De Palo G., Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 1994, 54:2032s-2037s.
6. Arsenou E.S., Papadimitriou E.P., Kliafa E., Hountalaand M., Nikolaropoulos S.S. Effects of retinoic acid steroidal analogs on human leukemic HL60 cell proliferation in vitro and on angiogenesis in vivo. Anti-Cancer Drugs 2005, 16:151-158.
7. Juhl H.J., Schürer C.C., Bartram C.R., Kohl F.V., Melderis H., von Wichert P., Rüdiger H.W. Retinoids induce sister-chromatid exchanges in human diploid fibroblasts. Mutat. Res. 1978, 58:317-320.
8. Sirianni S.R., Chen H.H., Huang C.C. Effect of retinoids on plating efficiency sister-chromatid exchange (SCE) and mitomycin-C-induced SCE in cultured Chinese hamster cells. Mutat. Res. 1981, 90:175-182.
9. Watanabe T., Pratt R.M. Influence of retinoids on sister chromatid exchanges and chromosomes in cultured human embryonic palatal mesenchymal cells. Teratogen. Carcin. Mut. 1991, 11:297-304.
10. Aydemir N., Celikler S., Bilaloĝlu R. In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes. Mutat. Res. 2005, 582:35-41.
11. El-Zein R.A., Schabath M.B., Etzel C.J., Lopez M.S., Franklin J.D., Spitz M.R. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006, 66:6449-6456.
12. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2007, 2:1084-1104.
13. Degrassi F., Tanzarella C. Immunofluorescent staining of kinetochores in micronuclei: a new assay for the detection of aneuploidy. Mutat. Res. 1988, 203:339-345.
14. Norppa H., Falck G.C. What do human micronuclei contain?. Mutagenesis 2003, 18:221-233.
15. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M.J., Kirchner S., Lorge E., Morita T., Norppa H., Surrallés J., Vanhauwaert A., Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 2003, 540:153-163.
16. Schuler M., Rupa D.S., Eastmond D.A. A critical evaluation of centromeric labeling to distinguish micronuclei induced by chromosomal loss and breakage in vitro. Mutat. Res. 1997, 392:81-95.
17. Stephanou G., Russo A., Vlastos D., Andrianopoulos C., Demopoulos N.A. Micronucleus induction in somatic cells of mice as evaluated after 1,3-butadiene inhalation. Mutat. Res. 1998, 397:11-20.
18. Stephanou G., Andrianopoulos C., Tyrakis M., Konti M., Demopoulos N.A., Tsambaos D. In vitro antigenotoxic potential of acitretin in human lymphocytes treated with the antineoplastic alkylating agent ASE (NSC-71964). Toxicol. in Vitro 2004, 18:609-616.
19. Efthimiou M., Andrianopoulos C., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N,N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro. Mutat. Res. 2007, 617:125-137.
20. Efthimiou M., Ouranou D., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S., Alevizos P. Comparative study of genetic activity of chlorambucil's active metabolite steroidal esters: the role of steroidal skeleton on aneugenic potential. Mutat. Res. 2010, 689:1-11.
21. Kirsch-Volders M., Vanhauwaert A., De Boeck M., Decordier I. Importance of detecting numerical versus structural chromosome aberrations. Mutat. Res. 2002, 504:137-148.
22. Gatlin J.C., Bloom K. Microtubule motors in eukaryotic spindle assembly and maintenance. Semin. Cell Dev. Biol. 2010, 21:248-254.
23. E. Pasquier, M. Kavallaris, Microtubules: A Dynamic Target in Cancer Therapy, IUBMB Life, 60 (2008) 165-170.
24. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., Decordier I. Indirect mechanism of genotoxicity. Toxicol. Lett. 2003, 140-141:63-74.
25. Meraldi P., Nigg E.A. The centrosome cycle. FEBS Lett. 2002, 521:9-13.
26. Zheng A., Savolainen E.R., Koistinen P. All-trans-retinoic acid induces apoptosis in acute myeloblastic leukaemia cells. Apoptosis 1997, 2:319-329.
27. Satoshi F., Suzumiya J., Anzai K., Ohkubo K., Hata T., Yamada Y., Kamihira S., Kikuchi M., Ono J. Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines. Leukemia Res. 1998, 22:611-618.
28. Kouloumenta A., Stephanou G., Demopoulos N.A., Nikolaropoulos S.S. Genetic effects caused by potent antileukemic steroidal esters of chlorambucil's active metabolite. Anticancer Drugs 2005, 16:67-75.
29. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727.
30. W.R. Thompson, B. Nadal-Ginard, V. Mahdavi, A MyoD1-independent muscle-specific enhancer controls the expression of the β-myosin heavy chain gene in skeletal and cardiac muscle cells. J Biol Chem. 266 (1991) 22678-22688.
31. Guttridge D.C., Mayo M.W., Madrid L.V., Wang C.Y., Baldwin A.S.Jr. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000, 289:2363-2366.
32. Bhattacharyya B., Howard R., Maity S.N., Brossi A., Sharma P.N., Wolff J. B ring regulation of colchicine binding kinetics and fluorescence. Proc. Natl. Acad. Sci. 1986, 83:2052-2055.
33. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M.Jr., Lorge E., Norppa H., Surrallés J., von der Hude W., Wakata A. Report from the in vitro micronucleus assay working group. Environ. Mol. Mutagen. 2000, 35:167-172.
34. Surrallés J., Xamena N., Creus A., Catalán J., Norppa H., Marcos R. Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat. Res. 1995, 341:169-184.
35. Sokal R.R., Rohlf F.J. Biometry 1981, W.H. Freeman and Co., New York.
36. Snedecor G., Cochran W. Statistical Methods 1972, Iowa State University Press, Ames, IA.
37. Fachinetto J.M., Ourique A.F., Lubini G., Tedesco S.B., Silva A.C.F., Beck R.C.R. Tretinoin-loaded Polymeric Nanocapsules: Evaluation of the Potential to Improve the Antiproliferative Activities on Allium cepa root-tip Compared to the Free Drug. Lat. Am. J. Pharm. 2008, 27:668-673.
38. Murata M., Kawanishi S. Oxidative DNA damage by vitamin A and its derivative via superoxide generation. J. Biol. Chem. 2000, 275:2003-2008.
39. Conte da Frota Jr M.L., Gomes da Silva E., Behr G.A., Roberto de Oliveira M., Dal-Pizzol F., Klamt F., Moreira J.C. All-trans retinoic acid induces free radical generation and modulate antioxidant enzyme activities in rat sertoli cells. Mol. Cell Biochem. 2006, 285:173-179.
40. Mei N., Hu J., Xia Q., Fu P.P., Moore M.M., Chen T. Cytotoxicity and mutagenicity of retinol with ultraviolet A irradiation in mouse lymphoma cells. Toxicol. In Vitro 2010, 24:439-444.
41. Pettersson F., Colston K.W., Dalgleish A.G. Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells. Pancreas 2001, 23:273-279.
42. Wakino S., Kintscher U., Kim S., Jackson S., Yin F., Nagpal S., Chandraratna R.A., Hsueh W.A., Law R.E. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators. Arterioscler Thromb. Vasc. Biol. 2001, 21:746-751.
43. Seewaldt V.L., Kim J.H., Caldwell L.E., Johnson B.S., Swisshelm K., Collins S.J. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells. Cell Growth Differ. 1997, 8:631-641.
44. Wu S., Donigan A., Platsoucas C.D., Jung W., Soprano D.R., Soprano K.J. All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1. Exp. Cell Res. 1997, 232:277-286.
45. Guo J.M., Xiao B.X., Kang G.Z., Liu D.H., Chen H., Zhang S., Zhang X.N. Suppression of telomerase activity and arrest at G1 phase in human cervical cancer HeLa cells by all-trans retinoic acid. Int. J. Gynecol. Cancer 2006, 16:341-346.
46. Xiao B., Guo J., Lou Y., Meng D., Zhao W., Zhang L., Yan C., Wang D. Inhibition of growth and increase of alkaline phosphatase activity in cultured human oral cancer cells by all-trans retinoic acid. Int. J. Oral Maxillofac. Surg. 2006, 35:643-648.
47. Guo J., Xiao B., Lou Y., Yan C., Zhan L., Wang D., Zhao W. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells. J. Gastroenterol. Hepatol. 2006, 21:443-448.
48. Hanahan D., Weinberg R. The hallmarks of cancer. Cell 2000, 100:57-70.
49. Glover D.M., Leibowitz M.H., McLean D.A., Parry H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 1995, 81:95-105.
50. Rao X., Zhang Y., Yi Q., Hou H., Xu B., Chu L., Huang Y., Zhang W., Fenech M., Shi Q. Multiple origins of spontaneously arising micronuclei in HeLa cells: direct evidence from long-term live cell imaging. Mutat. Res. 2008, 646:41-49.
51. Basto R., Brunk K., Vinadogrova T., Peel N., Franz A., Khodjakov A., Raff J.W. Centrosome amplification can initiate tumorigenesis in flies. Cell 2008, 133:1032-1042.
52. Ring D., Hubble R., Kirschner M. Mitosis in a cell with multiple centrioles. J. Cell Biol. 1982, 94:549-556.
53. Murphy T.D. Drosophila skpA, a component of SCF ubiquitin ligases, regulates centrosome duplication independently of cyclin E accumulation. J. Cell Sci. 2003, 116:2321-2332.
54. Quintyne N.J., Reing J.E., Hoffelder D.R., Gollin S.M., Saunders W.S. Spindle multipolarity is prevented by centrosomal clustering. Science 2005, 307:127-129.
55. Fukasawa K. Introduction. Oncogene 2002, 21:6140-6145.
56. Fenech M., Crott J.W. Micronuclei, nucleoplasmic bridges and nuclear buds induced in folic acid deficient human lymphocytes-evidence for breakage-fusion-bridge cycles in the cytokinesis-block micronucleus assay. Mutat. Res. 2002, 504:131-136.
57. Gisselsson D., Björk J., Höglund M., Mertens F., Dal Cin P., Akerman M., Mandahl N. Abnormal nuclear shape in solid tumors reflects mitotic instability. Am. J. Pathol. 2001, 158:199-206.
58. Hoffelder D.R., Luo L., Burke N.A., Watkins S.C., Gollin S.M., Saunders W.S. Resolution of anaphase bridges in cancer cells. Chromosoma 2004, 112:389-397.
59. Gisselsson D., Jonson T., Petersén A., Strömbeck B., Dal Cin P., Höglund M., Mitelman F., Mertens F., Mandahl N. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc. Natl. Acad. Sci. USA 2001, 98:12683-12688.
60. McDermott K.M., Zhang J., Holst C.R., Kozakiewicz B.K., Singla V., Tlsty T.D. P16INK4a prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 2006, 4:350-365.
61. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
62. Roninson I.B., Broude E.V., Chang B. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Update 2001, 5:303-313.
63. Huang X., Tran T., Zhang L., Hatcher R., Zhang P. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc. Natl. Acad. Sci. 2005, 102:1065-1070.
64. Blajeski A.L., Phan V.A., Kottke T.J., Kaufmann S.H. G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J. Clin. Invest. 2002, 110:91-99.